Dr. Cara Elise Jones, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 710 Highway 1 South, Lugoff, SC 29078 Phone: 803-408-9589 Fax: 803-408-9854 |
Dr. Erin Rollings, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 Baldwin Ave, Lugoff, SC 29078 Phone: 803-438-5537 |
Dr. Alyssa L Norwood, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 40 Baldwin Ave, Lugoff, SC 29078 Phone: 803-438-5537 Fax: 803-438-5546 |
Lauren Mackey, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 415 Holly Berry Ln, Lugoff, SC 29078 Phone: 803-427-4652 |
Amelia Milejczak, PHARMD Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 40 Baldwin Ave, Lugoff, SC 29078 Phone: 803-438-5537 |
News Archive
Although normal inflammation plays an important role in helping to fight off infections, there is mounting evidence that chronic inflammation is linked to increased risk of tumor development. A new study conducted by researchers in the Charles E. Schmidt College of Medicine at Florida Atlantic University is helping to shed light on the important link between inflammation and cancer, and how pre-existing inflammation may aid in the metastatic process.
Canadian health groups today called on the Government of Canada to ban the exportation of pharmaceutical drugs from Canada to the U.S. The groups, who represent the interests of millions of Canadian patients, were in Washington to highlight their concerns with Internet pharmacies.
Fat tissue in women with Polycystic Ovary Syndrome produces an inadequate amount of the hormone that regulates how fats and glucose are processed, promoting increased insulin resistance and inflammation, glucose intolerance, and greater risk of diabetes and heart disease, according to a study conducted at the Center for Androgen-Related Research and Discovery at Cedars-Sinai Medical Center.
Jennerex, Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced in conjunction with Lee's Pharmaceutical Holdings, the execution of a collaboration and license agreement for Jennerex's lead product candidate, JX-594, in certain Asian territories.
HHS Secretary Kathleen Sebelius announced Tuesday during a House Energy and Commerce Committee hearing that H1N1 (swine flu) vaccines produced by four manufacturers — CSL Ltd., Novartis, Sanofi-Pasteur and Medimmune — had won FDA approval, paving the way for a U.S. large-scale vaccination campaign, The Wall Street Journal reports. The application for GlaxoSmithKline PLC's vaccine is still being considered (Dooren/Favole, 9/15).
› Verified 1 days ago